Concepedia

Dario Ballinari

DB

Statistics

Publications

38

Citations

3K

H-Index

26

Active since

1980

Affiliations

Nerviano Medical Sciences(Current)

Fondazione IRCCS Istituto Nazionale dei Tumori

European Institute of Oncology

Novartis (Switzerland)

University of Milan

Dario Ballinari is an author at Nerviano Medical Sciences specializing in pharmacology, medicine, and oncology.

Publications per year

1980–2017

38

Publications

38

Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death

Paola Magnaghi, Roberto D’Alessio, Barbara Valsasina et al. · Nature Chemical Biology · 2013 · 383 citations

Life Sciences, Cell Biology, Molecular Biology +10

Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications

Elena Ardini, Maria Menichincheri, Patrizia Banfi et al. · Molecular Cancer Therapeutics · 2016 · 312 citations · Full text

Medicine, Oncology, Pharmacology +17

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer

Patrizia Carpinelli, Roberta Ceruti, Maria Laura Giorgini et al. · Molecular Cancer Therapeutics · 2007 · 244 citations

Medicine, Oncology, Pharmacology +16

A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity

Alessia Montagnoli, Barbara Valsasina, Valter Croci et al. · Nature Chemical Biology · 2008 · 215 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity

Chiara Soncini, Patrizia Carpinelli, Laura Gianellini et al. · Clinical Cancer Research · 2006 · 161 citations

Medicine, Oncology, Pharmacology +16

1–5 of 38